Since all DCIS is not the same as regards malignant potential, Dr. Hwang describes a clinical trial which will hopefully provide some answers.
Where the DCIS contains hormone receptors, patients may be treated 3 months prior to surgery to monitor response to medical (hormonal) therapy and some may not even need surgery, or where a mastectomy may have been needed, it may be possible to conserve the breast.
Interviewee:
Shelley Hwang MD, MPH, Chief Breast Surgical Oncology UCSF Helen Diller Family Comprehensive Cancer Center
http://cancer.ucsf.edu
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c0d2f53ef01157072551a970c
Listed below are links to weblogs that reference A Clinical Trial Explaining DCIS: